2017
|
Invention
|
Pharmaceutical preparations containing highly volatile silicones. The subject of the present inve... |
2012
|
Invention
|
Erlotinib salts. The invention relates to erlotinib salts selected from the group consisting of t... |
|
Invention
|
New co crystals useful in the preparation of pharmaceutical compositions. The invention relates t... |
|
Invention
|
Pharmaceutical intermediates and process for the preparation thereof. The present invention relat... |
|
Invention
|
Process for the manufacture of dabigatran etexilate and intermediates thereof. The present invent... |
|
Invention
|
Process for the preparation of a rivaroxaban and intermediates formed in said process. The invent... |
2011
|
Invention
|
Method for the preparation of high-purity pharmaceutical intermediates. The present invention is ... |
|
Invention
|
Method for preparing rosuvastatin salts. The present invention is related to methods for the prep... |
|
Invention
|
New salts suitable for the preparation of pharmaceutical compositions. The invention relates to n... |
|
Invention
|
Crystalline pharmaceutically active ingredients. The present invention is related to crystalline ... |
|
Invention
|
Method for preparing pharmaceutically active ingredient and intermediates thereof. The present in... |
|
Invention
|
Method for purifying diatomaceous earth. A method for purifying diatomaceous earth, whose natural... |
|
Invention
|
Method for preparation of an excipient suitable for pharmaceutical use. The present invention is ... |
|
Invention
|
Method for purifying diatomaceous earth suitable for pharmaceutical use. The present invention is... |
|
Invention
|
Preparation process of vildagliptin. The object of the present invention is a process for prepari... |
|
Invention
|
New salts, polymorphs and solvates of febuxostat. The present invention relates to new salts of f... |
|
Invention
|
Disinfectant and antiseptic formulation having reduced iodine content. The invention is related t... |
|
Invention
|
Use of diatomaceous earth in the pharmaceutical industry.
The present invention is related to so... |
|
Invention
|
Use of diatomaceous earth in the pharmaceutical industry. The present invention is related to sol... |
|
Invention
|
Controlled release pharmaceutical composition. The present invention relates to a sustained relea... |
|
Invention
|
Stabilized pharmaceutical composition. The invention relates to stabilized pharmaceutical composi... |
|
Invention
|
Novel salts for the manufacture of pharmaceutical compositions. The present invention relates to ... |
2010
|
Invention
|
Process for preparing a pharmaceutical compound.
The object of the present invention is a one-po... |
|
Invention
|
Process for preparing pharmaceutical compounds and intermediate compounds. The object of the pres... |
|
Invention
|
Improved process for preparing a pharmaceutical compound. The object of the present invention is ... |
|
Invention
|
Inorganic salt complexes of vildagliptin. The present invention relates to the use of novel vilda... |
|
Invention
|
2,3,4-benzothiadiazepine-2,2-dioxide derivatives. The present invention relates to compounds 2,3,... |
|
Invention
|
Glycerol-free osmotic laxative suppository. The object of the present invention is an osmotic com... |
|
Invention
|
Rosuvastatin manganse, copper, iron and zinc salts with high photochemical stability. Rosuvastati... |
|
Invention
|
New granulating process and thus prepared granulate. The present invention relates to a process f... |
|
Invention
|
Method and apparatus for testing transdermal medicaments.
The invention relates to an apparatus ... |
|
Invention
|
Method and apparatus for testing transdermal medicaments. The invention relates to an apparatus a... |
|
Invention
|
Method and apparatus for testing transdermal medicaments. The invention relates to an appar... |
|
Invention
|
Transdermal pharmaceutical preparations.
The present invention relates to semisolid transdermal ... |
|
Invention
|
Transdermal pharmaceutical preparations. The present invention relates to semisolid transde... |
|
Invention
|
Transdermal pharmaceutical preparations. The present invention relates to semisolid transdermal p... |
|
Invention
|
Optically active 3-[(phenylpiperazin-1-yl)alkyl]-3- alkyl-oxindole derivatives having cns activit... |
2009
|
Invention
|
Crystalline form i rosuvastatin zinc salt. The present invention relates to crystalline Form I ro... |
2008
|
Invention
|
Process for the preparation of pharmaceutical intermediate.
The invention relates to a process f... |
|
Invention
|
Process for the preparation of pharmaceutical intermediates. 1-4 alkyl group, having a straight o... |
2007
|
Invention
|
Pharmaceutical intermediate for synthesizing ace inhibitors and the use thereof. 2 are as defined... |